FMOD and cardiomyopathy: In addition, ferroptosis-related genes could provide us with a novel direction of exploration in HCM and DCM, respectively, and 3 hub genes (POSTN, IGFBP5, and FMOD) could be potential biomarkers or therapeutic targets in cardiomyopathies.